TNX-801 is a single-dose, live virus vaccine in development to protect against mpox and smallpox TNX-801 protects ...

Emergent BioSolutions Inc.’s EBS share price has surged by 5.37%, which has investors questioning if this is right time to ...

Tonix Pharmaceuticals (TNXP) presented data in an oral presentation at the World Vaccine Congress Washington 2025, held April 21-24, 2025, in ...

In observance of World Immunisation Week, WHO's Saima Wazed emphasizes the importance of vaccines in protecting global health ...

Vaccines have saved more than 154 million lives worldwide over the past 50 years. World Immunization Week is a timely ...

One in five Irish people said they would not take a traditional vaccine, a worldwide research project found. A further one in ...

Sugar coatings aren't only for candies; they also help viruses, like the ones that cause COVID-19, hide from their hosts' immune system.

GEO-CM04S1 Demonstrates Durable T Cell and Antibody Responses in Healthy and Immunocompromised Populations ...

Britain is mounting a major pre-emptive strike against smallpox attack by germ war terrorists. Up to 60million doses of the vaccine are being stockpiled, enough to treat the entire population.

In recognition of World Immunisation Week (April 24–30), we explore how vaccines have transformed healthcare – and consider ...

Vaccine Nation is a warning about the acceleration of the anti-vaccination movement during the pandemic and worrying declines ...

Emergent BioSolutions has been given FDA approval to extend the indications for its smallpox vaccine ACAM2000 to include the prevention of mpox, currently deemed a public health emergency by the WHO.